J. Martin Carroll, Director at Esperion Therapeutics, Inc. (ESPR), bought 31,500 shares at $1.57 ($49K) on 2023-05-11, disclosed to the SEC on 2023-05-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.49 | 8,409 | $13K | 25.7% |
| 2 | $1.57 | 23,091 | $36K | 74.3% |
| Total | $1.55 avg | 31,500 | $49K | 100% |
| Filing → |
| MNK | BUY | 2017-11-13 | $204K | — | Filing → |
| ITEK | BUY | 2016-05-17 | $90K | — | Filing → |
| TXMD | BUY | 2015-05-12 | $61K | — | Filing → |